Pfizer was among the drugmakers most elevated by the COVID-19 pandemic, and, going forward, the pharma giant has no plans to give up on its current momentum, according to a press release from the company.
But what Twitter is releasing about the company may change all of that momentum.
That’d be a huge increase from 2020, when the drugmaker pulled down $41.9 billion globally. Of course, Pfizer’s trajectory changed after the company launched its massively successful COVID-19 vaccine Comirnaty and its antiviral Paxlovid.
To reach those 2030 revenue goals, the company is entering “the most important 18 months in the history of Pfizer,” Bourla said Monday. That’s because the company is planning 19 drug launches or label expansions over the next year and a half.
Those launches, in total, should generate $20 billion in sales by 2030, Bourla said. The group includes an RSV vaccine, elranatamab in multiple myeloma, ritlecitinib in alopecia areata and many other products.
Beyond those launches expected over the next 18 months, Bourla touted a pipeline of drugs expected to reach markets after the second half of 2024. Those include a much-anticipated oral GLP-1 drug, a gene therapy portfolio and several vaccines.
Here is what could derail it all.
“The latest release of the “Twitter Files” exposed actions taken by Pfizer board member and former FDA commissioner Dr. Scott Gottlieb to suppress debate over the necessity of COVID vaccines for those with natural immunity,” Western Journal reported, adding:
The findings were revealed by independent journalist Alex Berenson, a former New York Times reporter who gained recognition as a contrarian’s voice during the pandemic.
Berenson’s full report can be viewed on his Substack website, “Unreported Truths.”
One of the most notable revelations was that Gottlieb, in his official capacity for Big Pharma, had turned to the same Twitter lobbyist the Biden White House worked with to shut down a post from Dr. Brett Giroir, a one-time acting FDA commissioner, who tweeted that the vaccine was unnecessary for those with natural immunity.
In August 2021, the month before President Joe Biden announced his ill-advised and unconstitutional vaccine mandate, Giroir wrote: “It’s now clear #COVID19 natural immunity is superior to #vaccine immunity, by ALOT. There’s no scientific justification for #vax proof if a person had prior infection.”
Obviously, both Pfizer and Gottlieb were acutely interested in keeping alive the cash cow their mRNA vaccine had become. According to Berenson, Pfizer’s mRNA vaccine contributed nearly 50 percent to the company’s 2021 revenue of $81 billion. And Gottlieb was paid $365,000 for his service on the Pfizer board that year.
With his financial interests in mind, Gottlieb emailed Todd O’Boyle, a senior manager in Twitter’s public policy department, to ask the company to remove the tweet.
Gottlieb wrote: “This is the kind of stuff that’s corrosive. Here he draws a sweeping conclusion off a single retrospective study in Israel that hasn’t been peer reviewed. But this tweet will end up going viral and driving news coverage.”
O’Boyle forwarded Gottlieb’s email to the company’s strategic response team with a message that said, “Please see this report from the former FDA commissioner.” Berenson noted that O’Boyle omitted the fact that Gottlieb was a member of Pfizer’s board.
Despite a strategic response team member’s reply that the tweet did not violate Twitter’s misinformation rules, the company nevertheless put a “misleading” warning on it which, Berenson wrote, prevented “almost anyone from seeing it.”
1/ My first #TwitterFiles report: how @scottgottliebmd – a top Pfizer board member – used the same Twitter lobbyist as the White House to suppress debate on Covid vaccines, INCLUDING FROM A FELLOW HEAD OF @US_FDA!
Thanks @elonmusk for opening these files,” Alex Berenson (@AlexBerenson) posted on Twitter on January 9, 2023.
1/ My first #TwitterFiles report: how @scottgottliebmd – a top Pfizer board member – used the same Twitter lobbyist as the White House to suppress debate on Covid vaccines, INCLUDING FROM A FELLOW HEAD OF @US_FDA!
Thanks @elonmusk for opening these files.https://t.co/UbHlmtjELP
— Alex Berenson (@AlexBerenson) January 9, 2023
2/ In August 2021, Gottlieb told Todd O’Boyle – a senior manager in Twitter’s public policy department – that a tweet from @drgiroir claiming CORRECTLY that natural immunity was superior to vaccine immunity was “corrosive” and might “go viral.”
3/ Twitter put a misleading tag on the tweet, preventing it from being shared. Gottlieb then went after a tweet about Covid’s low risk to kids from @justin_hart. Pfizer would soon win the okay for its mRNA shots for children, so keeping parents scared was crucial…
3/ Twitter put a misleading tag on the tweet, preventing it from being shared. Gottlieb then went after a tweet about Covid's low risk to kids from @justin_hart. Pfizer would soon win the okay for its mRNA shots for children, so keeping parents scared was crucial…
— Alex Berenson (@AlexBerenson) January 9, 2023
4/ In October 2022, @scottgottliebmd claimed on Twitter and CNBC that he was not trying to suppress debate on mRNA jabs. These files prove that Gottlieb – board member at a company that has made $70 billion on the shots – did just that.
4/ In October 2022, @scottgottliebmd claimed on Twitter and CNBC that he was not trying to suppress debate on mRNA jabs. These files prove that Gottlieb – board member at a company that has made $70 billion on the shots – did just that.
Full story here:https://t.co/UbHlmtjELP
— Alex Berenson (@AlexBerenson) January 9, 2023
“Scott Gottlieb‘s behavior speaks for itself. A former FDA commissioner (now Pfizer board member) schemed with a lobbyist & @Twitter to apparently put corporate interests first — not public health. If anything, we need more open, honest, uncensored debate – not less,” Brett Giroir posted.
